This concept isn’t new—in fact, it is the essence of representational state transfer (REST). Instead of converting to a ...
Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...
SAN FRANCISCO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...
SAN FRANCISCO, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...
Dec 8 (Reuters) - Structure Therapeutics (GPCR.O), opens new tab said on Monday its obesity pill showed weight loss of up to 11.3% after 36 weeks of treatment in a mid-stage study, driving the company ...
Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...
Wuthering Waves 3.0 livestream is available on both YouTube and Twitch.
PETALING JAYA: Analysts deem MISC Bhd ’s recent charter contract win from PETRONAS Carigali Brunei Ltd (PCBL) for the Kelidang Cluster floating production, storage and offloading (FPSO) vessel in ...
(WJET/WFXP)– The City of Erie’s Redevelopment Authority announced a new program giving homeowners some financial help with demolishing old, blighted structures like detached garages on their property.
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. For tech start-ups, relentless focus can be critical. Google’s famous mission statement, to “organise the world ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback